Panel recommends epidemiological study on endosulfan impact

Image
Press Trust of India Thiruvananthapuram
Last Updated : Apr 13 2017 | 4:22 PM IST
Kerala State Commission for Protection of Child Rights has recommended the government to conduct an epidemiological study on the impact of endosulfan, a banned pesticide, on human beings and nature.
The Commission, which recently carried out a study on various issues faced by endosulfan victim children in Kasaragod district, suggested to earmark a separate fund in the state budget to meet their needs.
Endosulfan had been sprayed on cashew plantations of Kasaragod several years ago, contaminating soil and water and causing serious health hazards to people in the northern district.
An epidemiological study on various hazards posed by endosulfan on human beings and other flora and fauna is inevitable. It should cover the risk factors and methods to check related diseases due to the usage of endosulfan, the Commission said in its recommendation.
Facilities to carry out such a study should be set up in endosulfan-hit Kasaragod, it said.
The rights panel also suggested the government to ensure free distribution of medicines for victims in hospitals and launch facilities for physiotherapy and speech therapy in community health centres and district-taluk hospitals.
A comprehensive database of victim children should be prepared and steps should be initiated to provide the details to the stakeholders online.
Considering the plight of the endosulfan victims, state Health Secretary should take steps to fill the posts of specialist doctors in hospitals and community centres in Kasaragod, it said.
The Commission also directed the Chief Secretary to form a separate tribunal to provide compensation for the endosulfan victims.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 13 2017 | 4:22 PM IST

Next Story